Clinical trials for Quality of Life

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44394 clinical trials with a EudraCT protocol, of which 7406 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (8,251)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18)

8,251 result(s) found for: Quality of Life. Displaying page 199 of 413.

EudraCT Number: 2004-001965-16	Sponsor Protocol Number: 101-AC-OSL-124	Start Date*: 2005-01-26
Sponsor Name:LABORATORIOS LETI
Full Title: ENSAYO CLÍNICO, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO CONTROLADO CON PLACEBO, DE INMUNOTERAPIA SUBLINGUAL CON EXTRACTO ALERGÉNICO DE DERMATOPHAGOIDES PTERONYSSINUS EN PACIENTES CON ASMA, DE INTE...
Medical condition: La inmunoterapia consiste en la administración, generalmente subcutánea, de dosis progresivamente crecientes del material alergénico al que el paciente está sensibilizado, con el fin de mejorar la ...
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-002642-35	Sponsor Protocol Number: SHR-5/S 04	Start Date*: 2006-03-08
Sponsor Name:Green Medicine AB
Full Title: A randomized double-blind placebo-controlled parallel group study of SHR -5 extract of Rhodiola Rosea as adjuvant therapy in patients with stress related fatigue.
Medical condition: Burnout syndrome
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: (No results available)

EudraCT Number: 2004-002427-40	Sponsor Protocol Number: 2602	Start Date*: 2007-11-08
Sponsor Name:Newcastle Upon Tyne Hospitals NHS Foundation Trust
Full Title: What is the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin?
Medical condition: Upper limb spasticity following stroke
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results

EudraCT Number: 2006-005218-11

Sponsor Protocol Number: FARM58SK29

Start Date*: 2006-09-15

Sponsor Name:ASSOCIAZIONE ITALIANA ENDOCRINOLOGIA-METABOLISMO-IPOFISI

Full Title: EFFECTIVENESS AND TOLERABILITY OF TREATMENT WITH CABERGOLINE IN PATIENTS WITH CUSHING S SYNDROME

Medical condition: Cushing syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10011652	Cushing's syndrome	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-005221-37

Sponsor Protocol Number: ASF-1075-204

Start Date*: 2006-12-20

Sponsor Name:Astion Danmark A/S

Full Title: Efficacy and safety of ASF-1075 cream 2.5% and 5% on pruritus in patients with lichen simplex chronicus (neurodermatitis) of the anogenital region. A phase II, multi-centre, double-blind, vehicle-c...

Medical condition: Lichen simplex chronicus (LSC), also called neruodermatitis.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10057292	Lichen simplex chronicus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-016158-42

Sponsor Protocol Number: IT-04-1-8-09

Start Date*: 2009-12-23

Sponsor Name:U.L.S.S. 16

Full Title: Efficacy of intravitreal bevacizumab for exudative age-related macular degeneration.

Medical condition: Exudative age-related macular degeneration

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10015902	Exudative senile macular degeneration of retina	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-007180-16

Sponsor Protocol Number: RITIS

Start Date*: 2009-05-13

Sponsor Name:LUMC

Full Title: INFLUENCE OF B CELL DEPLETION BY MONOCLONAL ANTI-CD20 ANTIBODIES IN SYSTEMIC SCLERODERMA

Medical condition: systemic sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10039710	Scleroderma	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-012956-26

Sponsor Protocol Number: 1690

Start Date*: 2009-06-08

Sponsor Name:AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA

Full Title: Randomized clinical trial on efficacy and tolerability of intra-articular clodronate compared to placebo in knee osteoarthritis

Medical condition: Knee osteoarthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10048794	Gonarthrosis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2010-023507-95

Sponsor Protocol Number: 2010B151

Start Date*: 2011-01-20

Sponsor Name:BASICS Study Group

Full Title: Basilar Artery International Cooperation Study Trial

Medical condition: Basilar artery occlusion.

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	10029205 - Nervous system disorders	10063093	Basilar artery thrombosis	PT
	18.0	10029205 - Nervous system disorders	10048963	Basilar artery occlusion	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing) DE (Completed) IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-000215-22	Sponsor Protocol Number: HH3104994	Start Date*: 2006-02-08
Sponsor Name:GlaxoSmithKline Research & Development Ltd
Full Title: A randomised, double blind, placebo controlled, two-way crossover, three phase, study, to investigate the trial models, Vienna Challenge Chamber, in and out of season, and Park Study in season and ...
Medical condition: Seasonal Allergic Rhinitis (SAR)
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results

EudraCT Number: 2006-004662-14

Sponsor Protocol Number: S06 GenMed601

Start Date*: 2007-02-22

Sponsor Name:Swansea NHS Trust

Full Title: Randomized, controlled, parallel-group study to investigate the clinical effictiveness of early insulin treatment in patients with latent autoimmune diabetes in adults [LADA]

Medical condition: LADA: Latent autoimmune diabetes in adults

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10012601	Diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2005-000848-83

Sponsor Protocol Number: CSO181

Start Date*: 2005-07-06

Sponsor Name:GlaxoSmithKline Consumer Healthcare GmbH & Co KG, 77815 Bühl

Full Title: Teilverblindete, randomisierte, Placebo-kontrollierte, multizentrische Studie zur Wirksamkeit von Dickextrakt aus Kürbissamen (Kürbissamen-Extrakt) und Kürbissamen bei Patienten mit benigner Prosta...

Medical condition: benign prostatic hyperplasia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.0		10004446		LLH

Population Age: Adults, Elderly

Gender: Male

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2004-001164-41	Sponsor Protocol Number: 2-55-58035-002	Start Date*: 2004-11-25
Sponsor Name:Beaufour Ipsen Pharma
Full Title: AN EXPLORATORY, OPEN, TWO-ARM, MATCH-CONTROL, RANDOMISED AND STRATIFIED PILOT PHASE II STUDY ASSESSING THE PREVENTION OF THE ADVERSE EFFECTS OF LONG-TERM HIGH-DOSE GLUCOCORTICOID THERAPY BY GROWTH ...
Medical condition: Adverse effects of the long-term high-dose glucocorticoid administration in naïve children with chronic disease.
Disease:
Population Age:		Gender:
Trial protocol: SE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2006-002385-20

Sponsor Protocol Number: CAO/ARO/AIO-04

Start Date*: 2006-06-28

Sponsor Name:Strahlenklinik, Universitätsklinikum Erlangen, insoweit handelnd für den Freistaat Bayern

Full Title: Prospective randomised multicenter phase-III-study: Preoperative radiochemotherapy and adjuvant chemotherapy with 5-Fluorouracil plus oxaliplatin versus preoperative radiochemotherapy and adjuvant...

Medical condition: Male or femal patients suffering from histologically proven carcinoma of the rectum (tumor ≤ 12cm from the anal verge, with clinically staged T3/4 or any node-positive disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10038039	Rectal neoplasms malignant	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2008-000814-65

Sponsor Protocol Number: PACT-12

Start Date*: 2008-02-26

Sponsor Name:OSPEDALE S. RAFFAELE DI MILANO

Full Title: Maintenance therapy with Sunitinib in pancreatic adenocarcinoma metastatic: Phase II randomized trial.

Medical condition: Pancreatic adenocarcinoma metastatic

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004864	10033599	Pancreatic adenocarcinoma metastatic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2010-023090-19

Sponsor Protocol Number: SMR 2375

Start Date*: 2011-03-29

Sponsor Name:AlgiPharma AS

Full Title: A double-blind, randomized, placebo-controlled, cross-over study to evaluate the safety, tolerability and preliminary efficacy of alginate oligosaccharide (OligoG) administered for 28 days in subje...

Medical condition: Cystic Fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10010331 - Congenital, familial and genetic disorders	10011762	Cystic fibrosis	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) IE (Completed)

Trial results: (No results available)

EudraCT Number: 2008-002671-27

Sponsor Protocol Number: 28.04.2008

Start Date*: 2008-07-14

Sponsor Name:Department of Medical Gastroenterology

Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP CLINICAL AND EXPERIMENTAL PILOTSTUDY OF PREGABALIN IN PATIENTS WITH CHRONIC PANCREATITIS

Medical condition: Chronic pancreatitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10033649	Pancreatitis chronic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed)

Trial results: (No results available)

EudraCT Number: 2014-000269-27	Sponsor Protocol Number: DSCK101	Start Date*: 2014-11-06
Sponsor Name:German Foundation for Chronically Ill
Full Title: Efficacy and tolerance of Beta Blocker and Procoralan uptitration in chronic heart failure patients under telemedical control: „70 bpm on day 28“
Medical condition: Patients with chronic heart failure and resting heart rate of ≥ 75 bmp
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Ongoing)
Trial results: (No results available)

EudraCT Number: 2013-004307-39

Sponsor Protocol Number: RG_13-090

Start Date*: 2015-01-08

Sponsor Name:University of Birmingham

Full Title: Response to Optimal Selection of neo-adjuvant Chemotherapy in Operable breast cancer: A randomised phase III, stratified biomarker trial of neo-adjuvant 5-Fluorouracil, Epirubicin and Cyclophospham...

Medical condition: Breast cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	17.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10006187	Breast cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2020-000866-41	Sponsor Protocol Number: 2019001_mife50	Start Date*: 2021-02-02
Sponsor Name:Women on Web International Foundation
Full Title: Combined Phase II/ III Multicentre Single-arm Trial of a Mifepristone 50 mg as a weekly Contraceptive
Medical condition: Prevention of unwanted pregnancy
Disease:
Population Age: Adults		Gender: Female
Trial protocol: Outside EU/EEA
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Thu May 28 19:23:59 CEST 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA